OLOID
Passwordless clinical access on shared workstations

OLOID provides badge, face, and PIN access for shared clinical workstations, with Epic authentication and prescribing support alongside identity systems.
Best for
- Health systems modernizing shared-workstation login while retaining their identity provider
- Clinical teams needing phone-free authentication at frequently shared devices
Not ideal for
- Buyers seeking every module in a broad clinical identity suite
- Organizations expecting compatibility without testing their badges, readers, and EHR workflows

Bottom line
OLOID is worth considering for health systems seeking phone-free, passwordless clinical access while retaining their existing identity provider. Its strongest fit is a defined shared-workstation and Epic authentication project with a carefully validated rollout.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
OLOID is relevant to health systems replacing repeated password entry on shared PCs, workstations on wheels, and virtual desktops. Clinicians can use a badge or biometric factor while keeping the organization’s established identity provider. Imprivata is a genuine alternative for this clinical shared-access job, with a broader portfolio and a larger healthcare footprint.
This is an enterprise authentication deployment with software, integration, and operational validation costs. It should be compared with the clinical-access portion of an existing identity stack. General workforce SSO or remote-access MFA alone does not necessarily provide fast user switching and in-workflow authentication at a shared clinical workstation.
- Outcomes and workflow value (7.4): Clinical workflow documentation supports a meaningful access use case, while comparative hospital-scale outcome evidence is less developed.
- Product and service depth (8.0): Shared-device authentication, fast switching, Epic contexts, and EPCS support address clinical requirements.
- Ease of implementation (7.1): Existing identity-provider integration can reduce duplication, but workstation, badge, and clinical signing validation remain substantial.
- Pricing clarity (6.0): Deployment pricing requires a quote; public dollar rates are not supplied.
Where OLOID Fits in Clinical Access
The reviewed clinical-access documentation describes badge, face, and PIN factors, shared-workstation switching, and connections to identity providers such as Microsoft Entra ID, Okta, and Ping. The intended benefit is individual access on a device that many staff members use during a shift.
OLOID also describes an Epic integration and electronic prescribing of controlled substances, or EPCS, workflows. These are more specific than generic corporate SSO. The contract and pilot should identify the exact Epic environment, signing context, supported factors, and audit records that the deployment will use.
Security Depends on the Whole Workflow
A quick login is useful only if it opens the correct person’s session and closes or locks the previous one appropriately. Enrollment, badge replacement, account recovery, offline operation, and access logs are therefore part of the clinical-access design. A lost badge or interrupted network connection should have a defined response.
The company describes biometric and EPCS certifications in its product materials. Those claims concern specific components and configurations, not automatic approval of every possible customer workflow. Clinical and security teams should validate the complete prescribing and authentication arrangement before using it in production.
Replacement Scope and Deployment Evidence
OLOID’s own competitor article positions it as a clinical authentication layer alongside an existing identity provider. It acknowledges Imprivata’s broader adjacent modules and healthcare installed base. That is a useful distinction for a hospital deciding which licenses can be replaced and which functions still need coverage.
The article is vendor-authored, so its comparisons should be checked in a practical pilot. Testing should include the actual reader and badge fleet, virtual desktops, shift changes, prescribing workflows, accessibility needs, and recovery paths. Claims about consolidation do not establish lower total cost until the required modules and migration work are counted.
Product and service details: oloid.com, oloid.com.
Company scale
LeadIQ estimates OLOID’s annual revenue at $10 million to $25 million. Scale source
What People Say
What people like
"I want to tap in at a shared workstation without entering a password every time."
"Keeping our existing identity provider would reduce the amount of identity infrastructure we have to change."
What people don't like
"We still need to test our badges, virtual desktops, and prescribing workflows before replacing clinical access."
Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.
Based on: Product or service details, Product or service details.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| OLOID | 7.3 | 7.1 |
| Imprivata | 7.8 | 7.4 |
| Pointsharp | 7.3 | 7.0 |
Pricing
| Item | Detail |
|---|---|
| Commercial terms | Quote-based enterprise deployment; no public clinical-workstation dollar rate. |
| Scope | Users, endpoints, factors, badge and reader compatibility, EHR connections, support, and rollout services. |
| Replacement analysis | Compare only the modules being replaced, including migration, training, recovery, and audit continuity. |
Leadership
Recent news
- May 2026: Ping Identity and OLOID announced a partnership to offer U.S. healthcare organizations identity proofing at onboarding, passwordless tap-and-login on shared workstations, and account recovery for clinical staff.
- March 2026: OLOID Passwordless was listed in the End-User Authentication Toolbox on Epic Showroom, giving Epic customers a listed option for passwordless sign-in on clinical workstations.
Methodology
We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.
Existing peer scores are carried from the linked HIR reviews.
Sources
- Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
- oloid.com · blog/imprivata competitors
- oloid.com · about
- leadiq.com · c/oloid/5e713c091d6f06b3827e5ff5
- oloid.com · author/mohit garg
